DK0598770T3 - Pyrazinderivater samt fremstilling og anvendelse deraf - Google Patents
Pyrazinderivater samt fremstilling og anvendelse derafInfo
- Publication number
- DK0598770T3 DK0598770T3 DK92916697.3T DK92916697T DK0598770T3 DK 0598770 T3 DK0598770 T3 DK 0598770T3 DK 92916697 T DK92916697 T DK 92916697T DK 0598770 T3 DK0598770 T3 DK 0598770T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- pyrazine derivatives
- compounds
- pyrazine
- derivatives
- Prior art date
Links
- 150000003216 pyrazines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000007796 conventional method Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4127026A DE4127026A1 (de) | 1991-08-16 | 1991-08-16 | Neue pyrazinderivate, ihre herstellung und verwendung |
| DE19914130461 DE4130461A1 (de) | 1991-09-13 | 1991-09-13 | Neue pyrazinderivate, ihre herstellung und verwendung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0598770T3 true DK0598770T3 (da) | 1997-12-15 |
Family
ID=25906394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK92916697.3T DK0598770T3 (da) | 1991-08-16 | 1992-07-31 | Pyrazinderivater samt fremstilling og anvendelse deraf |
Country Status (23)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6645969B1 (en) | 1991-05-10 | 2003-11-11 | Aventis Pharmaceuticals Inc. | Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
| IL109570A0 (en) * | 1993-05-17 | 1994-08-26 | Fujisawa Pharmaceutical Co | Guanidine derivatives, pharmaceutical compositions containing the same and processes for the preparation thereof |
| DE4325822A1 (de) * | 1993-07-31 | 1995-02-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5852046A (en) * | 1993-08-03 | 1998-12-22 | Hoechst Aktiengesellschaft | Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them |
| DE4337609A1 (de) * | 1993-11-04 | 1995-05-11 | Boehringer Ingelheim Kg | Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln |
| DE4412334A1 (de) * | 1994-04-11 | 1995-10-19 | Hoechst Ag | Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| US5760230A (en) * | 1996-10-11 | 1998-06-02 | Bayer Aktiengesellschaft | 4, 4'-bridged bis-2, 4-diaminoquinazolines |
| US6420354B1 (en) * | 1998-06-08 | 2002-07-16 | Advanced Medicine, Inc. | Sodium channel drugs and uses |
| IT1312310B1 (it) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
| AU4952700A (en) | 1999-06-03 | 2000-12-28 | Takeda Chemical Industries Ltd. | Pernasal preparations |
| US6479498B1 (en) | 1999-06-04 | 2002-11-12 | Theravance, Inc. | Sodium channel drugs and uses |
| US6156758A (en) * | 1999-09-08 | 2000-12-05 | Isis Pharmaceuticals, Inc. | Antibacterial quinazoline compounds |
| JP4836405B2 (ja) * | 2002-03-13 | 2011-12-14 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼの新規な阻害剤としてのアミノカルボニル誘導体 |
| US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
| CN1984660B (zh) | 2003-07-03 | 2010-12-15 | 美瑞德生物工程公司 | 作为天冬氨酸特异性半胱氨酸蛋白酶活化剂和细胞程序死亡诱导剂的4-芳基氨基-喹唑啉 |
| EP1668008A4 (en) | 2003-08-28 | 2009-02-25 | Nitromed Inc | NITROSED AND NITROSYLATED DIETETIC COMPOUNDS, COMPOSITIONS AND APPLICATION METHODS |
| US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
| EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
| EP1855688A4 (en) | 2005-02-24 | 2011-09-14 | Nicox Sa | NON-STAINED OXIDE DIURETIC COMPOUNDS, COMPOSITIONS AND USE PROCESSES |
| DE102008061247A1 (de) * | 2008-12-10 | 2010-06-24 | Christian-Albrechts-Universität Zu Kiel | Inhibitoren der Dimethylarginin Dimethylaminohydrolase |
| DK2615092T3 (en) * | 2010-09-10 | 2015-09-21 | Hangzhou Bensheng Pharmaceutical Co Ltd | Heterocyclic AMINOBERBAMIN DERIVATIVES, PREPARATION METHOD AND USE THEREOF |
| CN110041291B (zh) * | 2018-01-15 | 2021-02-26 | 北京采瑞医药科技研究院有限公司 | 一种玛咖酰胺衍生物及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL299931A (enrdf_load_stackoverflow) * | 1962-10-30 | |||
| US3527758A (en) * | 1967-04-13 | 1970-09-08 | Merck & Co Inc | Process for the preparation of pyrazinoylguanidines from a pyrazinoic azide and a guanidine |
| US3539569A (en) * | 1968-08-21 | 1970-11-10 | Merck & Co Inc | Preparation of pyrazinoylguanidines from pyrazinoylureas |
| NL7803906A (nl) * | 1978-04-12 | 1979-10-16 | Noordvos Schroeven Bv | Werkwijze, inrichting en propeller voor het verdelen van een gasvormig, poedervormig of vloeibaar materiaal in een vloeistof. |
| GB8712365D0 (en) * | 1987-05-26 | 1987-07-01 | Ici America Inc | Aminomethylphenolic pyrazines |
-
1992
- 1992-07-28 TW TW081105973A patent/TW213903B/zh active
- 1992-07-31 HU HU9400430A patent/HUT67661A/hu unknown
- 1992-07-31 ES ES92916697T patent/ES2108129T3/es not_active Expired - Lifetime
- 1992-07-31 DE DE59208974T patent/DE59208974D1/de not_active Expired - Fee Related
- 1992-07-31 DK DK92916697.3T patent/DK0598770T3/da active
- 1992-07-31 RU RU94015265A patent/RU2124008C1/ru active
- 1992-07-31 HK HK98102228A patent/HK1003137A1/xx not_active IP Right Cessation
- 1992-07-31 CZ CZ94337A patent/CZ280760B6/cs unknown
- 1992-07-31 AT AT92916697T patent/ATE159250T1/de not_active IP Right Cessation
- 1992-07-31 WO PCT/EP1992/001738 patent/WO1993004048A1/de active IP Right Grant
- 1992-07-31 EP EP92916697A patent/EP0598770B1/de not_active Expired - Lifetime
- 1992-07-31 SG SG1996002613A patent/SG46307A1/en unknown
- 1992-07-31 AU AU23870/92A patent/AU669122B2/en not_active Ceased
- 1992-07-31 FI FI940696A patent/FI940696A0/fi unknown
- 1992-07-31 JP JP5504057A patent/JPH06509798A/ja active Pending
- 1992-07-31 SK SK175-94A patent/SK17594A3/sk unknown
- 1992-07-31 CA CA002115755A patent/CA2115755A1/en not_active Abandoned
- 1992-08-11 MX MX9204637A patent/MX9204637A/es not_active IP Right Cessation
- 1992-08-14 IL IL102814A patent/IL102814A0/xx unknown
- 1992-08-14 NZ NZ243959A patent/NZ243959A/en unknown
- 1992-08-17 IE IE259292A patent/IE922592A1/en not_active IP Right Cessation
-
1994
- 1994-02-15 NO NO940523A patent/NO301542B1/no unknown
-
1997
- 1997-12-23 GR GR970403392T patent/GR3025742T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ33794A3 (en) | 1994-07-13 |
| FI940696L (fi) | 1994-02-15 |
| JPH06509798A (ja) | 1994-11-02 |
| GR3025742T3 (en) | 1998-03-31 |
| SG46307A1 (en) | 1998-02-20 |
| NO940523D0 (no) | 1994-02-15 |
| CZ280760B6 (cs) | 1996-04-17 |
| RU2124008C1 (ru) | 1998-12-27 |
| NZ243959A (en) | 1995-07-26 |
| WO1993004048A1 (de) | 1993-03-04 |
| DE59208974D1 (de) | 1997-11-20 |
| IE922592A1 (en) | 1993-02-24 |
| HU9400430D0 (en) | 1994-05-30 |
| NO940523L (no) | 1994-02-15 |
| TW213903B (enrdf_load_stackoverflow) | 1993-10-01 |
| EP0598770A1 (de) | 1994-06-01 |
| ATE159250T1 (de) | 1997-11-15 |
| ES2108129T3 (es) | 1997-12-16 |
| CA2115755A1 (en) | 1993-03-04 |
| NO301542B1 (no) | 1997-11-10 |
| HUT67661A (en) | 1995-04-28 |
| AU2387092A (en) | 1993-03-16 |
| RU94015265A (ru) | 1997-02-20 |
| SK17594A3 (en) | 1994-12-07 |
| EP0598770B1 (de) | 1997-10-15 |
| IL102814A0 (en) | 1993-01-31 |
| AU669122B2 (en) | 1996-05-30 |
| FI940696A7 (fi) | 1994-02-15 |
| MX9204637A (es) | 1993-02-01 |
| HK1003137A1 (en) | 1998-10-09 |
| FI940696A0 (fi) | 1994-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0598770T3 (da) | Pyrazinderivater samt fremstilling og anvendelse deraf | |
| SE8700498D0 (sv) | Novel pharmaceologically active compounds | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| IL76457A0 (en) | Tetralin derivatives,their preparation and pharmaceutical compositions containing them | |
| AU2724292A (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of alpha-d-neuraminic acid | |
| ES2075202T3 (es) | Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen. | |
| ZA948669B (en) | New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions | |
| AU611113B2 (en) | Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds | |
| AU1891683A (en) | Substituted 1-phenyl-isoquinoline anti-arrythmic agents | |
| AU530678B2 (en) | Phosphono-hydroxy-acetic acid | |
| KR960004860B1 (en) | Substituted pyridine-2,4-dicarboxylic acid compounds and the use thereof and medicaments | |
| FI884960A0 (fi) | Anvaendning av 2-pyrimidinyl-1-piperazin-derivat. | |
| NZ220800A (en) | Tetrahydrobenzothiazoles and pharmaceutical compositions | |
| ITMI911845A1 (it) | Uso dei derivati dell'acido benzimidazolin-2-oxo-1-carbossilico. | |
| SE8204792D0 (sv) | N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt | |
| IL67400A0 (en) | 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them | |
| SE8603517L (sv) | Heterocykliska foreningar och deras framstellning och farmaceutiska formuleringar | |
| BG90609A (bg) | Производни на пирола, методи за получаване и приложение | |
| FR2676448B1 (fr) | Nouveaux derives amidiques de 1-amino octahydropyrido [2,1-c] [1,4] oxazine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| DE69002027D1 (de) | (3-diethylaminopropyl)-1-amino-5-methyldipyrido(4,3-b)(3,4-f)indoltrihydrochlorid. |